TRAP-14 amide trifluoroacetate salt,CAS :141923-36-6
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-NH₂ trifluoroacetate salt
Product description
TRAP-14 amide, SFLLRNPNDKYEPF-NH2, has been shown to inhibit monocyte spreading on fibronectin-coated slides. The rapidly induced withdrawal of pseudopodial processes and rounding of the cells is accompanied by nitric oxide and endothelin-1 release. Spreading might be inhibited by autocrine endothelin-1 release and subsequent endothelin B receptor-dependent nitric oxide production.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Cas | 141923-36-6 |
| Sequence | SFLLRNPNDKYEPF-NH₂ |
| Synonyms | Thrombin Receptor Activator Peptide 14 amide, Coagulation Factor II Receptor (1-14) amide (human), PAR-1 (1-14) amide (human), Thrombin Receptor (1-14) amide (human) |
| Molecular Formula | C₈₁H₁₁₉N₂₁O₂₂ |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of TRAP-14 amide trifluoroacetate salt
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


